|
|
First Patient Enrolled in New Study Assessing early prediction of flares in Atopic Dermatitis by Castle Biosciences in Collaboration with SciBase |
|
|
Study that highlights Nevisense potential for prediction of AD published in leading journal |
|
|
SciBase announces that the board of directors has resolved on the record date for the reverse share split |
|
|
Nevisense detects skin barrier damage by chemicals used in household cleaning products in a new ex-vivo study |
|
|
Bulletin from the annual general meeting in SciBase Holding AB (publ) |
|
|
SciBase Announces New Research Highlighting Nevisense's Potential in Detecting Age-Related Skin Barrier Changes |
|
|
Interim report |
|
|
SciBase publishes the Annual report for 2025 |
|
|
Notice to attend the annual general meeting in Scibase Holding AB (publ) |
|
|
SciBase reaches milestone with over 400,000 tests sold with Nevisense |
